PMVP:PMV Pharmaceuticals Inc Snapshot | Charting | News | Options
$1.61   0.00%  $0.00 NASDAQ 8:00a ET
March 27 '24 		PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Reza... GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors
     GlobeNewswire
    Full Story →

    Headline News
    PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women's Cancer
    4:01p ET March 18 '24 GlobeNewswire
    PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights
    4:01p ET February 29 '24 GlobeNewswire
    PMV Pharmaceuticals to Participate in the TD Cowen 44th Annual Health Care Conference
    8:00a ET February 26 '24 GlobeNewswire
    More News →
    Day  0.00%Week  1.90%Month  4.73%More Charting →
    April 17 '24. Markets Closed.
    Last $1.61
    Day change   0.00%$0.00
    Open $NA
    Gap at open $NA
    Previous close $1.61
    Trading volume NA
    10 Day avg vol. 543,434
    Shares out. 51.4Mil
    Market cap. $82.8Mil
    Trading activity Below Avg.
    Previous data from yesterday, April 17 '24.

    Historical Price Performance
    3 month   0.00% 
    6 month   8.05% 
    1 year   65.60% 
    2 year   90.03% 

    Earnings
    Previous 12m -$1.44
    Next 12m Estimate -$1.38
    P/E ratio 1.1x
    Revenue 0Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.